Skip to main content

Advertisement

ADVERTISEMENT

News

News
07/11/2024
The presence of a foreign substance has prompted Dr Reddy’s Laboratories Inc. to recall allopurinol tablets distributed in 3 states.
The presence of a foreign substance has prompted Dr Reddy’s Laboratories Inc. to recall allopurinol tablets distributed in 3 states.
The presence of a foreign...
07/11/2024
Pharmacy Learning Network
News
07/11/2024
Dr Reddy’s Laboratories Inc. is recalling 13 752 bottles of eszopiclone tablets for failing to meet impurity/degradation specifications.
Dr Reddy’s Laboratories Inc. is recalling 13 752 bottles of eszopiclone tablets for failing to meet impurity/degradation specifications.
Dr Reddy’s Laboratories Inc. is...
07/11/2024
Pharmacy Learning Network

Advertisement

News
07/11/2024
A Class I recall has been issued for Ram It and To The Moon capsules distributed by Integrity Products after an FDA analysis found the dietary supplements were tainted with sildenafil and tadalafil.
A Class I recall has been issued for Ram It and To The Moon capsules distributed by Integrity Products after an FDA analysis found the dietary supplements were tainted with sildenafil and tadalafil.
A Class I recall has been issued...
07/11/2024
Pharmacy Learning Network
News
07/03/2024
Georgia State University researchers are developing new tools and technologies to improve treatment, prevention, and detection of respiratory syncytial virus (RSV), with potential applications in drug screening and vaccine development.
Georgia State University researchers are developing new tools and technologies to improve treatment, prevention, and detection of respiratory syncytial virus (RSV), with potential applications in drug screening and vaccine development.
Georgia State University...
07/03/2024
Pharmacy Learning Network
News
07/03/2024
Central Admixture Pharmacy Services Inc. is recalling nearly 5000 hydromorphone injections because of a lack of assurance of sterility. Specifically, the injections lack validation data for sanitization cycles, according to recall...
Central Admixture Pharmacy Services Inc. is recalling nearly 5000 hydromorphone injections because of a lack of assurance of sterility. Specifically, the injections lack validation data for sanitization cycles, according to recall...
Central Admixture Pharmacy...
07/03/2024
Pharmacy Learning Network

Advertisement

News
07/03/2024
Some 2640 syringes containing vecuronium are being recalled by Central Admixture Pharmacy Services Inc. for sterility concerns. A recall announcement recently added to the US Food and Drug Administration (FDA) Enforcement Report website...
Some 2640 syringes containing vecuronium are being recalled by Central Admixture Pharmacy Services Inc. for sterility concerns. A recall announcement recently added to the US Food and Drug Administration (FDA) Enforcement Report website...
Some 2640 syringes containing...
07/03/2024
Pharmacy Learning Network
News
07/03/2024
Numerous fentanyl products are under a Class II recall because of a lack of assurance of sterility. According to recall announcements added to the US Food and Drug Administration (FDA) Enforcement Report website over the past week, the...
Numerous fentanyl products are under a Class II recall because of a lack of assurance of sterility. According to recall announcements added to the US Food and Drug Administration (FDA) Enforcement Report website over the past week, the...
Numerous fentanyl products are...
07/03/2024
Pharmacy Learning Network
News
06/27/2024
More than 70 000 vials of dexamethasone sodium phosphate injection are under recall for an impurity.
More than 70 000 vials of dexamethasone sodium phosphate injection are under recall for an impurity.
More than 70 000 vials of...
06/27/2024
Pharmacy Learning Network

Advertisement

News
06/27/2024
Eugia US is recalling 15 500 single-dose vials of eptifibatide injection.
Eugia US is recalling 15 500 single-dose vials of eptifibatide injection.
Eugia US is recalling 15 500...
06/27/2024
Pharmacy Learning Network
News
06/19/2024
Jolynn Tumolo
Pacira Pharmaceuticals Inc. is recalling 43 768 kits of Zilretta (triamcinolone acetonide extended-release injectable suspension) for failing stability testing.
Pacira Pharmaceuticals Inc. is recalling 43 768 kits of Zilretta (triamcinolone acetonide extended-release injectable suspension) for failing stability testing.
Pacira Pharmaceuticals Inc. is...
06/19/2024
Pharmacy Learning Network